Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study

by Gordon D, Hellriegel ET, Hope HR, Burt D, Monahan JB
Published 2021-06-01